4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001209191-16-132663
CIK 0001382911operating
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 1:32 PM ET
Size
8.2 KB
Accession
0001209191-16-132663
Insider Transaction Report
Form 4
Moglia Stephen A.
VP, Chief Accounting Officer
Transactions
- Award
Stock Option
2016-07-12+28,800→ 28,800 totalExercise: $15.00Exp: 2026-07-11→ Common Stock (28,800 underlying) - Award
Stock Option
2016-07-12+48,000→ 48,000 totalExercise: $4.02Exp: 2026-07-11→ Common Stock (48,000 underlying)
Footnotes (2)
- [F1]Thirty-three and one-third percent (33-1/3%) of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the one year anniversary of 07/12/2016, and 1/36 of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each month thereafter, so that all of the shares of the stock subject to the option shall be vested on the third (3rd) anniversary of 07/12/2016, subject to the employee's continued service relationship (whether as an employee, director or consultant) with the Corporation or any parent or subsidiary on each such date, as set forth in the applicable stock option grant notice and stock option agreement for such employee.
- [F2]Not Applicable
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 1:32 PM ET
- Size
- 8.2 KB